Skip to main
VTR
VTR logo

Ventas (VTR) Stock Forecast & Price Target

Ventas (VTR) Analyst Ratings

Based on 29 analyst ratings
Buy
Strong Buy 21%
Buy 48%
Hold 28%
Sell 3%
Strong Sell 0%

Bulls say

Ventas's diversified healthcare portfolio, comprising nearly 1,400 properties in senior housing, medical office spaces, hospitals, life sciences, and skilled nursing/post-acute care, positions the company well for sustained growth, particularly with an anticipated increase in SHOP concentration to over 50%. The estimated in-place net asset value (NAV) per share is projected to rise from $44.66 to $55.06 by year-end 2025, underscoring a robust growth outlook driven by strategic investments and a favorable operational environment. Additionally, with 29 operators collaborating, Ventas is poised to capitalize on its superior cost of capital to enhance accretive growth and potentially increase adjusted funds from operations (AFFO) estimates by over 10%.

Bears say

The financial outlook for Ventas is negatively impacted by an anticipated deterioration in the company’s cost of capital, limiting its ability to pursue new investment opportunities, which could lead to a decline in adjusted funds from operations (AFFO) estimates. Moreover, the outlook for senior housing operating properties (SHOP) appears muted, with expectations of modest occupancy growth coupled with overall expense increases that may offset revenue growth, thus compressing valuation multiples. Additionally, a net debt to EBITDA ratio of 6.0x, exceeding the target range, alongside potential reductions in funding from the National Institutes of Health (NIH), pose significant risks to the company’s financial stability and growth prospects.

Ventas (VTR) has been analyzed by 29 analysts, with a consensus rating of Buy. 21% of analysts recommend a Strong Buy, 48% recommend Buy, 28% suggest Holding, 3% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Ventas and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Ventas (VTR) Forecast

Analysts have given Ventas (VTR) a Buy based on their latest research and market trends.

According to 29 analysts, Ventas (VTR) has a Buy consensus rating as of Jul 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $61.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $61.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Ventas (VTR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.